Real-World 4 And 5-Year Outcomes For Patients Treated With The Istent Inject (G2) Minimally Invasive Glaucoma Surgery Device

Published 2024 - 42nd Congress of the ESCRS

Reference: FP23.04 | Type: Free paper | DOI: 10.82333/1pws-t397